Viking Therapeutics, Inc. Share Price: VKTX (Viking Therapeutics, Inc.) Stock Price Today & Updates | INDmoney

Question 1

What is Viking Therapeutics, Inc. share price today?

Accepted Answer

Viking Therapeutics, Inc. (VKTX) share price today is {{live_price}}.

Question 2

Can Indians buy Viking Therapeutics, Inc. shares?

Accepted Answer

Yes, Indians can invest in the Viking Therapeutics, Inc. (VKTX) from India.

With INDmoney, you can buy Viking Therapeutics, Inc. at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Viking Therapeutics, Inc. at zero transaction cost.

Question 3

How can I buy Viking Therapeutics, Inc. shares from India?

Accepted Answer

It is very easy to buy Viking Therapeutics, Inc. from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Question 4

Can Fractional shares of Viking Therapeutics, Inc. be purchased?

Accepted Answer

Yes, you can buy fractional shares of Viking Therapeutics, Inc. with INDmoney app.

Question 5

What are the documents required to start investing in Viking Therapeutics, Inc. stocks?

Accepted Answer

To start investing in Viking Therapeutics, Inc., You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

Question 6

What are today’s High and Low prices of Viking Therapeutics, Inc.

Accepted Answer

Today’s highest price of Viking Therapeutics, Inc. (VKTX) is {{1_rba_end}}.

Today’s lowest price of Viking Therapeutics, Inc. (VKTX) is {{1_rba_st}}.

Question 7

What is today's market capitalisation of Viking Therapeutics, Inc.

Accepted Answer

Today's market capitalisation of Viking Therapeutics, Inc. VKTX is 7.3B

Question 8

What is the 52 Week High and Low Range of Viking Therapeutics, Inc.

Accepted Answer

52 Week High
{{rba_end}}
52 Week Low
{{rba_st}}

Question 9

How much percentage Viking Therapeutics, Inc. is down from its 52 Week High?

Accepted Answer

Viking Therapeutics, Inc. (VKTX) share price is {{live_price}}. It is down by {{w52lu}}% from its 52 Week High price of {{rba_end}}.

Question 10

How much percentage Viking Therapeutics, Inc. is up from its 52 Week low?

Accepted Answer

Viking Therapeutics, Inc. (VKTX) share price is {{live_price}}. It is up by {{w52hd}}% from its 52 Week Low price of {{rba_st}}.

Question 11

What are the historical returns of Viking Therapeutics, Inc.?

Accepted Answer

1 Month Returns
{{1mr}}%
3 Months Returns
{{3mr}}%
1 Year Returns
{{1yr}}%
5 Years Returns
{{5yr}}%

Question 12

Who is the Chief Executive Officer (CEO) of Viking Therapeutics, Inc.

Accepted Answer

Dr. Brian  Lian Ph.D. is the current Chief Executive Officer (CEO) of Viking Therapeutics, Inc..

Period	Viking Therapeutics, Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	232.28%	-1.3%	0.0%
6 Months	731.56%	12.4%	0.0%
1 Year	259.76%	4.6%	0.0%
3 Years	1173.28%	15.7%	-21.9%

Market Capitalization	7.3B
Book Value	$8.47
Earnings Per Share (EPS)	-0.91
PEG Ratio	-0.03
Wall Street Target Price	113.8

Profit Margin	0.0%
Operating Margin TTM	0.0%

Return On Assets TTM	-12.78%
Return On Equity TTM	-17.55%

Revenue TTM	0.0
Revenue Per Share TTM	0.0
Quarterly Revenue Growth YOY	0.0%
Gross Profit TTM	0.0
Diluted Eps TTM	-0.91
Quarterly Earnings Growth YOY	0.0

Viking Therapeutics, Inc. (VKTX)

Performance

Returns

Highlights

Analyst Recommendation

Analyst Forecast

Technicals Summary

Peers

Institutional Holdings

Corporate Announcements

Viking Therapeutics, Inc. Earnings

Company Information

Discover More

FAQs

EPS Estimate Current Year	-1.13
EPS Estimate Next Year	-1.53
EPS Estimate Current Quarter	-0.25
EPS Estimate Next Quarter	-0.27

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Viking Therapeutics, Inc.	0.1%	731.56%	259.76%	1173.28%	915.05%
Moderna, Inc.	4.46%	44.76%	-17.31%	-40.7%	317.84%
Regeneron Pharmaceuticals, Inc.	-8.11%	12.56%	10.41%	82.28%	161.35%
Novo Nordisk A/s	0.6%	31.36%	53.28%	240.62%	422.33%
Vertex Pharmaceuticals Incorporated	-6.58%	6.36%	13.86%	80.23%	127.58%

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Viking Therapeutics, Inc.	Buy	$7.3B	915.05%	NA	0.0%
Moderna, Inc.	Buy	$41.7B	317.84%	24.73	-68.84%
Regeneron Pharmaceuticals, Inc.	Buy	$99.5B	161.35%	26.04	30.14%
Novo Nordisk A/s	Buy	$562.8B	422.33%	47.43	36.03%
Vertex Pharmaceuticals Incorporated	Buy	$103.6B	127.58%	28.81	36.68%

Organization	Viking Therapeutics, Inc.
Employees	27
CEO	Dr. Brian Lian Ph.D.
Industry	Health Technology